Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AANEBULO PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

ANEBULO PHARMACEUTICALS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Apr 4, 2025Kupchyk AretaDirector27,647Stock Option (right to buy)—Grant / award
Apr 4, 2025English Aron R.Director, 10% Owner27,647Stock Option (right to buy)—Grant / award
Apr 4, 2025SHAH BIMAL R.Director31,618Stock Option (right to buy)—Grant / award
Apr 4, 2025Cundy Kenneth CChief Scientific Officer115,037Stock Option (right to buy)—Grant / award
Apr 4, 2025Lin KennethDirector29,964Stock Option (right to buy)—Grant / award
Apr 4, 2025Aryeh JasonDirector29,964Stock Option (right to buy)—Grant / award
Apr 4, 2025Lawler Joseph F.Director, 10% Owner38,236Stock Option (right to buy)—Grant / award
Apr 4, 2025Calloway NathanielDirector28,309Stock Option (right to buy)—Grant / award
Apr 4, 2025Cunningham, Richard AnthonyChief Executive Officer316,352Stock Option (right to buy)—Grant / award
Dec 23, 2024English Aron R.Director, 10% Owner10,101,010Common Stock—Buy
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.32Close · Oct 6, 2026